CARLSMED, INC.CARLEarnings & Financial Report
Nasdaq
NextMar 31, 2026
CARL Q3 2025 Key Financial Metrics
Revenue
$13.1M
Gross Profit
$9.9M
Operating Profit
$-9.0M
Net Profit
$-8.5M
Gross Margin
75.9%
Operating Margin
-69.1%
Net Margin
-65.2%
YoY Growth
98.4%
EPS
$-0.40
Financial Flow
CARLSMED, INC. Q3 2025 Financial Summary
CARLSMED, INC. reported revenue of $13.1M for Q3 2025, with a net profit of $-8.5M (-65.2% margin). Cost of goods sold was $3.1M, operating expenses totaled $19.0M.
Key Financial Metrics
| Total Revenue | $13.1M |
|---|---|
| Net Profit | $-8.5M |
| Gross Margin | 75.9% |
| Operating Margin | -69.1% |
| Report Period | Q3 2025 |
Income Statement
| Q2 2024 | Q3 2024 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|
| Revenue | $6.1M | $6.6M | $12.1M | $13.1M |
| YoY Growth | N/A | N/A | 98.7% | 98.4% |
Balance Sheet
| Q2 2024 | Q3 2024 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|
| Assets | N/A | N/A | $53.3M | $134.9M |
| Liabilities | N/A | N/A | $27.6M | $28.2M |
| Equity | $-57.7M | $-66.0M | $-83.1M | $106.7M |
Cash Flow
| Q3 2025 | |
|---|---|
| Operating CF | $-8.5M |